321 related articles for article (PubMed ID: 31466586)
21. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
[TBL] [Abstract][Full Text] [Related]
22. Clinical, histopathological, immunophenotypic and molecular analysis of 60 patients with cutaneous T-cell infiltrates with follow up of indeterminate cases to identify T-cell lymphoma.
Eros N; Károlyi Z; Marschalkó M; Kárpáti S; Matolcsy A
Pathol Oncol Res; 2008 Mar; 14(1):63-7. PubMed ID: 18392954
[TBL] [Abstract][Full Text] [Related]
23. Current status of cutaneous T-cell lymphoma: molecular diagnosis, pathogenesis, therapy and future directions.
Dippel E; Klemke CD; Goerdt S
Onkologie; 2003 Oct; 26(5):477-83. PubMed ID: 14605466
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
[TBL] [Abstract][Full Text] [Related]
25. Durable loss of a malignant T-cell clone in a stage IV cutaneous T-cell lymphoma patient treated with high-dose interferon and photopheresis.
Haley HR; Davis DA; Sams WM
J Am Acad Dermatol; 1999 Nov; 41(5 Pt 2):880-3. PubMed ID: 10534677
[TBL] [Abstract][Full Text] [Related]
26. Primary cutaneous T-cell lymphoma: review and current concepts.
Siegel RS; Pandolfino T; Guitart J; Rosen S; Kuzel TM
J Clin Oncol; 2000 Aug; 18(15):2908-25. PubMed ID: 10920140
[TBL] [Abstract][Full Text] [Related]
27. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
28. Immunophenotyping and gene rearrangement analysis provide additional criteria to differentiate between cutaneous T-cell lymphomas and pseudo-T-cell lymphomas.
Bakels V; van Oostveen JW; van der Putte SC; Meijer CJ; Willemze R
Am J Pathol; 1997 Jun; 150(6):1941-9. PubMed ID: 9176388
[TBL] [Abstract][Full Text] [Related]
29. Early intervention of extracorporeal photopheresis for advancing/progressing cutaneous T-cell lymphoma.
Aires D; Abhyankar S
Hematol Oncol; 2023 Dec; 41(5):809-816. PubMed ID: 37974524
[TBL] [Abstract][Full Text] [Related]
30. Management of refractory early-stage cutaneous T-cell lymphoma.
Huber MA; Staib G; Pehamberger H; Scharffetter-Kochanek K
Am J Clin Dermatol; 2006; 7(3):155-69. PubMed ID: 16734503
[TBL] [Abstract][Full Text] [Related]
31. Erythrodermic CTCL: updated clues to diagnosis and treatment.
Bernengo MG; Quaglino P
G Ital Dermatol Venereol; 2012 Dec; 147(6):533-44. PubMed ID: 23149699
[TBL] [Abstract][Full Text] [Related]
32. Junctional CD8+ cutaneous lymphomas with nonaggressive clinical behavior: a CD8+ variant of mycosis fungoides?
Dummer R; Kamarashev J; Kempf W; Häffner AC; Hess-Schmid M; Burg G
Arch Dermatol; 2002 Feb; 138(2):199-203. PubMed ID: 11843640
[TBL] [Abstract][Full Text] [Related]
33. [Rare variants of cutaneous T-cell lymphomas].
Goerdt S; Trautmann C; Kütting B; Ramaker J; Schmuth M; Thiel E; Luger T; Stein H; Orfanos CE
Hautarzt; 1996 Feb; 47(2):96-105. PubMed ID: 8868452
[TBL] [Abstract][Full Text] [Related]
34. [Current approaches to diagnosing and treating primary cutaneous lymphomas on the basis of a new WHO-EORTC classification, cutaneous T-cell lymphomas].
Belousova IE; Kazakov DV; Krivolapov IuA
Arkh Patol; 2007; 69(5):11-7. PubMed ID: 18074813
[TBL] [Abstract][Full Text] [Related]
35. Analysis of clonality in cutaneous T cell lymphoma and associated diseases.
Wood GS
Ann N Y Acad Sci; 2001 Sep; 941():26-30. PubMed ID: 11594579
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous T-cell lymphoma/leukemia.
Siegel RS; Kuzel TM
Curr Treat Options Oncol; 2000 Apr; 1(1):43-50. PubMed ID: 12057060
[TBL] [Abstract][Full Text] [Related]
37. [Current therapy concepts in cutaneous T-cell lymphomas].
Nestle FO; Häffner AC; Schmid MH; Dummer R; Burg G
Schweiz Med Wochenschr; 1997 Feb; 127(8):311-20. PubMed ID: 9157537
[TBL] [Abstract][Full Text] [Related]
38. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous T-cell lymphoma: a case study, treatment, and nursing implications.
Harris JS; Macey WH
Dermatol Nurs; 1994 Feb; 6(1):41-9. PubMed ID: 7946828
[TBL] [Abstract][Full Text] [Related]
40. T-cell receptor gene rearrangement in canine mycosis fungoides: further support for a canine model of cutaneous T-cell lymphoma.
Fivenson DP; Saed GM; Beck ER; Dunstan RW; Moore PF
J Invest Dermatol; 1994 Feb; 102(2):227-30. PubMed ID: 7906287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
